Jennifer E. Graser

Array ( [id] => 6000747 [patent_doc_number] => 20110117120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'Plasmodium falciparum HLA class I restricted T-cell epitopes' [patent_app_type] => utility [patent_app_number] => 12/942103 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8194 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117120.pdf [firstpage_image] =>[orig_patent_app_number] => 12942103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4613612 [patent_doc_number] => 07989610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Protein, a gene encoding therefor and a method of using the same' [patent_app_type] => utility [patent_app_number] => 12/942978 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15804 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989610.pdf [firstpage_image] =>[orig_patent_app_number] => 12942978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070161 [patent_doc_number] => 20110045011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'TRUNCATED RECOMBINANT MAJOR OUTER MEMBRANE PROTEIN ANTIGEN (R56) OF ORIENTIA TSUTSUGAMUSHI STRAINS KARP, KATO and GILLIAM AND ITS USE IN ANTIBODY BASED DETECTION ASSAYS AND VACCINES' [patent_app_type] => utility [patent_app_number] => 12/915193 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11642 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045011.pdf [firstpage_image] =>[orig_patent_app_number] => 12915193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8293987 [patent_doc_number] => 08221770 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis' [patent_app_type] => utility [patent_app_number] => 12/909621 [patent_app_country] => US [patent_app_date] => 2010-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 12 [patent_no_of_words] => 14240 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12909621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8652880 [patent_doc_number] => 08372626 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'L-arabinose fermenting yeast' [patent_app_type] => utility [patent_app_number] => 12/909523 [patent_app_country] => US [patent_app_date] => 2010-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 25 [patent_no_of_words] => 17305 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12909523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9749608 [patent_doc_number] => 08841080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'System for determining unprocessed and partially processed neurotoxin type A' [patent_app_type] => utility [patent_app_number] => 13/503128 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8984 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 307 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209051 [patent_doc_number] => 20120128707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'STREPTOCOCCUS PNEUMONIAE PROTEINS AND NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 12/897952 [patent_app_country] => US [patent_app_date] => 2010-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23036 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128707.pdf [firstpage_image] =>[orig_patent_app_number] => 12897952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453237 [patent_doc_number] => 20120264183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'Cellulose and Xylan Fermentation by Novel Anaerobic Thermophilic Clostridia Isolated From Self-Heated Biocompost' [patent_app_type] => utility [patent_app_number] => 13/498861 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6082 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13498861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5975969 [patent_doc_number] => 20110070256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'Vaccine Antigens from Piscirickettsia Salmonis' [patent_app_type] => utility [patent_app_number] => 12/886256 [patent_app_country] => US [patent_app_date] => 2010-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21217 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20110070256.pdf [firstpage_image] =>[orig_patent_app_number] => 12886256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697076 [patent_doc_number] => 20110229514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'VACCINE AND IMMUNIZATION METHOD USING PLASMODIUM ANTIGEN 2' [patent_app_type] => utility [patent_app_number] => 12/881604 [patent_app_country] => US [patent_app_date] => 2010-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14009 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229514.pdf [firstpage_image] =>[orig_patent_app_number] => 12881604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054594 [patent_doc_number] => 20110110954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Anthrax compositions and methods of use and production' [patent_app_type] => utility [patent_app_number] => 12/807833 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16355 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110954.pdf [firstpage_image] =>[orig_patent_app_number] => 12807833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8452728 [patent_doc_number] => 20120263674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'PSEUDOMONAS EXOTOXIN A WITH REDUCED IMMUNOGENICITY' [patent_app_type] => utility [patent_app_number] => 13/395422 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23299 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7790958 [patent_doc_number] => 20120052514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'Potency Test for Vaccine Formulations' [patent_app_type] => utility [patent_app_number] => 12/875618 [patent_app_country] => US [patent_app_date] => 2010-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5584 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20120052514.pdf [firstpage_image] =>[orig_patent_app_number] => 12875618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007088 [patent_doc_number] => 20110059119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'IMMUNOGEN AGAINST CAMPYLOBACTER INFECTION' [patent_app_type] => utility [patent_app_number] => 12/874304 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2733 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059119.pdf [firstpage_image] =>[orig_patent_app_number] => 12874304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7518503 [patent_doc_number] => 07972604 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Recombinant attenuated clostridium organisms and vaccine' [patent_app_type] => utility [patent_app_number] => 12/869813 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 12872 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/972/07972604.pdf [firstpage_image] =>[orig_patent_app_number] => 12869813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10870063 [patent_doc_number] => 08895257 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Proteins used for the diagnosis of lyme borreliosis' [patent_app_type] => utility [patent_app_number] => 13/388168 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7564 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8642822 [patent_doc_number] => 08367810 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-05 [patent_title] => 'Purified plasmodium and vaccine compositions' [patent_app_type] => utility [patent_app_number] => 12/870102 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 13820 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12870102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615725 [patent_doc_number] => 20100310569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae' [patent_app_type] => utility [patent_app_number] => 12/860332 [patent_app_country] => US [patent_app_date] => 2010-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26614 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310569.pdf [firstpage_image] =>[orig_patent_app_number] => 12860332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254421 [patent_doc_number] => 08617832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Method for identifying an agent that inhibits Candida albicans—mediated host cell differentiation' [patent_app_type] => utility [patent_app_number] => 13/391722 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9273 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6353916 [patent_doc_number] => 20100331537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'NOVEL SURFACE ANTIGEN' [patent_app_type] => utility [patent_app_number] => 12/841457 [patent_app_country] => US [patent_app_date] => 2010-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13827 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331537.pdf [firstpage_image] =>[orig_patent_app_number] => 12841457 [rel_patent_id] =>[rel_patent_doc_number] =>)